ARTES and Minapharm joint forces

ARTES Biotechnology GmbH, Germany, and Minapharm Pharmaceuticals and Chemical Industries S.A.E., Egypt, jointly announced today the formation of a new strategic business pact, offering packet solution for biopharmaceutical processes .   Aim of this new strategic business cooperation is to jointly out-license combinations of ARTES’ and Minapharm’s respective proprietary technologies and products to third parties […]

ARTES successfully completed EU funded project Plurivax

ARTES Biotechnology explored very effective in a SME consortium vaccine developments for veterinary applications. Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform and stable formulation especially suited for the veterinary applications, the EU cooperation was part of the 8th EuroTransBio call and was funded in the time period from […]

ARTES attends Bio-Europe Spring 2018

Meet us at the Bio-Europe Spring 2018 tak­ing place in Amsterdam March 12 -14. Michael Pio­ntek, Man­ag­ing Direc­tor at ARTES, will be present in the One-on-One Part­ner­ing presenting ARTES’ innovative range of cell line and process development solutions for bio-pharmaceutical and vaccine products. Con­tact us pre­vi­ous­ly for orga­niz­ing a per­son­al meet­ing or drop us a […]